THE FUTURE IS ENGINEERED: AI, BIOTECH, AND THE RISE OF STRATEGIC INNOVATION HUBS

The discussion centers on the future of innovation hubs, particularly in AI and biotech. Panelists are analyzing the competitive landscape between the US, China, and emerging players like Saudi Arabia and the UAE. Sebastian Kurz emphasizes the importance of avoiding over-regulation to attract talent, while Dr. Eric Lee highlights China's rapid growth in biotech patents and clinical development. Bob Nelson urges countries like Saudi Arabia to create their own path through regulatory innovation and data-driven healthcare systems. Irene Hong stresses the importance of focusing on patient outcomes rather than solely on competition. The conversation also touches on the impact of AI on various sectors, including synthetic biology and robotics. Panelists debate whether AI and biotech leadership is a zero-sum game, with some advocating for a play-to-win strategy. Ultimately, the panelists agree that adaptability and resilience are crucial in the face of an uncertain future.